SHELBY DEFARIA: Open Payments
NPI 1376233817 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 58 payments from 10 companies in 2025. Trend: 2023 $1,073 · 2024 $2,107 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $306 |
| Collegium Pharmaceutical, Inc. | 15 | $151 |
| Globus Medical, Inc. | 4 | $148 |
| ABBVIE INC. | 5 | $119 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $114 |
| Lilly USA, LLC | 4 | $110 |
| Valinor Pharma, LLC | 5 | $97 |
| Averitas Pharma Inc. | 3 | $81 |
| Novo Nordisk Inc | 3 | $62 |
| Tonix Medicines, Inc. | 2 | $46 |
Products named: RELISTOR, XTAMPZA, Senza, JOURNAVX, ZEPBOUND, MOVANTIK, QUTENZA, QULIPTA.
Industry payments across RI — which companies pay providers there.
